Bigul

AARTI DRUGS LTD. - 524348 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Cancellation of Schedule of Analyst/ Institutional Investor meetings
22-11-2023

AARTI DRUGS LTD. - 524348 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Intimation of issue of duplicate share certificate
21-11-2023

AARTI DRUGS LTD. - 524348 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Intimation of Loss of share certificate
16-11-2023

AARTI DRUGS LTD. - 524348 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Intimation of Analyst meet
16-11-2023

AARTI DRUGS LTD. - 524348 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Intimation of loss of share certificate
04-11-2023

AARTI DRUGS LTD. - 524348 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Intimation of Analyst Meet
02-11-2023

AARTI DRUGS LTD. - 524348 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

Transcript of earning call for Q2 & H1 FY24
27-10-2023

AARTI DRUGS LTD. - 524348 - Newspaper Publication Of Financial Results

Newspaper publication of financial results for the quarter and half year ended September 30, 2023
23-10-2023

AARTI DRUGS LTD. - 524348 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

Recording of Earning Conference call
20-10-2023

Aarti Drugs Results Earnings Call for Q2FY24

Conference Call with Aarti Drugs Management and Analysts on Q2FY24 Performance and Outlook. Listen to the full earnings transcript.
20-10-2023